Can large language models truly support regulatory-grade pharmaceutical communication?
As the GLP-1 landscape evolves rapidly, the industry requires more than generative outputs. It requires measurable evidence, regulatory confidence, and real-life relevance.
This 20-minute briefing explores:
• Accuracy in AI-generated healthcare content
• Regulatory suitability of generic LLMs
• The need for measurable, quality-controlled AI frameworks in Pharma
Discover what real-life Consumer conversations reveal about the evolving GLP-1 journey, from dose adjustments and weight loss plateaus to discontinuation, persistence, and the branded vs compounded debate.
Quickly solving a problem. Using real-life health related data to inform strategy. Shift from planning assumptions to real-life intelligence – powered by behavior, sentiment and engagement data.
DrugVoice turns unstructured HCP data into Predictive HCP Intelligence, revealing how scientific messaging lands and influences HCP behavior.